590 results
-
List item
Withdrawn application: Pioglitazone Teva Generics
pioglitazone, date of withdrawal: 26/01/2012, Initial authorisation, Last updated: 03/07/2012Pioglitazone Teva Generics: Withdrawn applicati … authorisation) Pioglitazone Teva Generics pioglitazone On … medicinal product Pioglitazone Teva Generics 15, 30, 45 mg tablet … -
List item
Withdrawn application: Clopidogrel Teva Pharma
clopidogrel, date of withdrawal: 22/04/2009, Initial authorisation, Last updated: 23/04/2009Clopidogrel Teva Pharma: Withdrawn application … application for Clopidogrel Teva Pharma clopidogrel … clopidogrel On 22 April 2009, Teva Pharma B.V. officially notified … -
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva (updated)
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 31/03/2009,
, Revision: 15, Withdrawn, Last updated: 09/07/2021
Ribavirin Teva Hepatitis C, Chronic … authorisation of Ribavirin Teva has been withdrawn at the … Summary documents Ribavirin Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Tevagrastim
filgrastim, Neutropenia, Hematopoietic Stem Cell Transplantation, Cancer
Date of authorisation: 15/09/2008,
, Revision: 14, Authorised, Last updated: 26/04/2021
Tevagrastim Neutropenia Hematopoietic … part of the EPAR). What is Tevagrastim? Tevagrastim is a solution for injection … active substance filgrastim. Tevagrastim is a ‘biosimilar medicine' … -
List item
Human medicine European public assessment report (EPAR): Olanzapine Teva
olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 12/12/2007,, Revision: 28, Authorised, Last updated: 08/04/2021
Olanzapine Teva Schizophrenia Bipolar Disor … EPAR). What is Olanzapine Teva? Olanzapine Teva is a medicine containing … in the mouth. Olanzapine Teva is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Levetiracetam Teva
levetiracetam, Epilepsy
Date of authorisation: 25/08/2011,, Revision: 17, Authorised, Last updated: 31/03/2021
Levetiracetam Teva Epilepsy … EPAR) for Levetiracetam Teva. It explains how the Committee … of use for Levetiracetam Teva. What is Levetiracetam Teva? Levetiracetam Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Telmisartan Teva
telmisartan, Hypertension
Date of authorisation: 25/01/2010,, Revision: 11, Authorised, Last updated: 25/03/2021
Telmisartan Teva Hypertension … report (EPAR) for Telmisartan Teva. It explains how the Committee … conditions of use for Telmisartan Teva. What is Telmisartan Teva? Telmisartan Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Nevirapine Teva
nevirapine, HIV Infections
Date of authorisation: 30/11/2009,, Revision: 10, Authorised, Last updated: 18/03/2021
Nevirapine Teva HIV Infections … EPAR). What is Nevirapine Teva? Nevirapine Teva is a medicine that contains … tablets (200 mg). Nevirapine Teva is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Entacapone Teva
entacapone, Parkinson Disease
Date of authorisation: 18/02/2011,, Revision: 9, Authorised, Last updated: 11/03/2021
Entacapone Teva Parkinson Disease … report (EPAR) for Entacapone Teva. It explains how the Committee … conditions of use for Entacapone Teva. What is Entacapone Teva? Entacapone Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Repaglinide Teva
repaglinide, Diabetes Mellitus, Type 2
Date of authorisation: 28/06/2009,, Revision: 8, Authorised, Last updated: 12/03/2021
Repaglinide Teva Diabetes Mellitus, Type 2 … EPAR). What is Repaglinide Teva? Repaglinide Teva is a medicine that contains … peach: 2 mg). Repaglinide Teva is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Irbesartan Teva
irbesartan, Hypertension
Date of authorisation: 30/10/2009,, Revision: 14, Authorised, Last updated: 11/03/2021
Irbesartan Teva Hypertension … EPAR). What is Irbesartan Teva? Irbesartan Teva is a medicine that contains … 150 and 300 mg). Irbesartan Teva is a ‘ A generic medicine … -
List item
Human medicine European public assessment report (EPAR): Capecitabine Teva
capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012,
, , Revision: 14, Authorised, Last updated: 17/03/2021
Capecitabine Teva Colonic Neoplasms Breast … capecitabine Overview Capecitabine Teva is a cancer medicine that … bowel) cancer. Capecitabine Teva is used on its own or with … -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva
lamivudine, Hepatitis B, Chronic
Date of authorisation: 23/10/2009,, Revision: 10, Authorised, Last updated: 26/02/2021
Lamivudine Teva Hepatitis B, Chronic … report (EPAR) for Lamivudine Teva. It explains how the Committee … conditions of use for Lamivudine Teva. What is Lamivudine Teva? Lamivudine Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Desloratadine Teva
desloratadine, Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Seasonal
Date of authorisation: 24/11/2011,, Revision: 16, Authorised, Last updated: 11/03/2021
Desloratadine Teva Rhinitis, Allergic, Perennial Rhinitis … EPAR) for Desloratadine Teva. It explains how the Committee … of use for Desloratadine Teva. What is Desloratadine Teva? Desloratadine Teva is a medicine containing … -
List item
Human medicine European public assessment report (EPAR): Imatinib Teva
imatinib, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Hypereosinophilic Syndrome, Dermatofibrosarcoma
Date of authorisation: 07/01/2013,, Revision: 15, Authorised, Last updated: 29/01/2021
Imatinib Teva Leukemia, Myelogenous, Chronic … report (EPAR) for Imatinib Teva. It explains how the Agency … advice on how to use Imatinib Teva. For practical information … -
List item
Human medicine European public assessment report (EPAR): Sildenafil Teva
sildenafil, Erectile Dysfunction
Date of authorisation: 30/11/2009,, Revision: 15, Authorised, Last updated: 13/10/2020
Sildenafil Teva Erectile Dysfunction … report (EPAR) for Sildenafil Teva. It explains how the Committee … conditions of use for Sildenafil Teva. What is Sildenafil Teva? Sildenafil Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva
docetaxel, Head and Neck Neoplasms, Carcinoma, Non-Small-Cell Lung, Adenocarcinoma, Prostatic Neoplasms, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 26/01/2010,, Revision: 18, Authorised, Last updated: 23/11/2020
Docetaxel Teva Head and Neck Neoplasms Carcinoma … docetaxel Overview Docetaxel Teva is a cancer medicine used … breast cancer. Docetaxel Teva can be used on its own after … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Teva
temozolomide, Glioma, Glioblastoma
Date of authorisation: 28/01/2010,, Revision: 19, Authorised, Last updated: 10/07/2020
Temozolomide Teva Glioma Glioblastoma … EPAR). What is Temozolomide Teva? Temozolomide Teva is a medicine that contains … and 250 mg). Temozolomide Teva is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Efavirenz Teva
efavirenz, HIV Infections
Date of authorisation: 09/01/2012,, Revision: 9, Authorised, Last updated: 17/10/2019
Efavirenz Teva HIV Infections … report (EPAR) for Efavirenz Teva. It explains how the Committee … conditions of use for Efavirenz Teva. What is Efavirenz Teva? Efavirenz Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Cabazitaxel Teva
cabazitaxel, Prostatic Neoplasms
Date of refusal: 11/07/2019, Refused, Last updated: 24/07/2019Cabazitaxel Teva Prostatic Neoplasms … medicinal product Cabazitaxel Teva, intended for the treatment … applied for authorisation is Teva B.V. It may request a re-examination … -
List item
Human medicine European public assessment report (EPAR): Topotecan Teva
topotecan, Ovarian Neoplasms, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma
Date of authorisation: 21/09/2009,, Revision: 8, Withdrawn, Last updated: 13/07/2018
Topotecan Teva Ovarian Neoplasms Uterine … EPAR). What is Topotecan Teva? Topotecan Teva is a concentrate that is … substance topotecan. Topotecan Teva is a ‘generic medicine’ … -
List item
Human medicine European public assessment report (EPAR): Leflunomide Teva
leflunomide, Arthritis, Rheumatoid
Date of authorisation: 10/03/2011,, Revision: 6, Withdrawn, Last updated: 18/03/2014
Leflunomide Teva Arthritis, Rheumatoid … authorisation for Leflunomide Teva has lapsed because it has … Summary documents Leflunomide Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Teva
rivastigmine, Dementia, Alzheimer Disease, Parkinson Disease
Date of authorisation: 17/04/2009,, Revision: 4, Withdrawn, Last updated: 27/09/2012
Rivastigmine Teva Dementia Alzheimer Disease Parkinson … authorisation for Rivastigmine Teva has been withdrawn at the … Summary documents Rivastigmine Teva : EPAR - Summary for the … -
List item
Human medicine European public assessment report (EPAR): Pioglitazone Teva
pioglitazone hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 26/03/2012,, Revision: 11, Authorised, Last updated: 01/03/2021
Pioglitazone Teva Diabetes Mellitus, Type 2 … report (EPAR) for Pioglitazone Teva. It explains how the Committee … conditions of use for Pioglitazone Teva. What is Pioglitazone Teva? Pioglitazone Teva is a medicine that contains … -
List item
Human medicine European public assessment report (EPAR): Raloxifene Teva
raloxifene hydrochloride, Osteoporosis, Postmenopausal
Date of authorisation: 29/04/2010,, Revision: 9, Authorised, Last updated: 03/02/2021
Raloxifene Teva Osteoporosis, Postmenopausal … Report (EPAR) for Raloxifene Teva. It explains how the Committee … conditions of use for Raloxifene Teva. What is Raloxifene Teva? Raloxifene Teva is a medicine that contains …